Clinical and Genomic Insights Into of Chinese Lung Cancer Patients with HER2 Amplification

被引：0
|
作者：
Zhou, C. [1 ]
Ai, X. [2 ]
Gu, D. [3 ]
Chen, R. [3 ]
Xia, X. [3 ]
机构：
[1] Guangzhou Med Univ, Guangzhou Inst Resp Hlth, Affiliated Hosp 1, Resp Med Dept,State Key Lab Resp Dis,Natl Clin Re, Guangzhou, Peoples R China
[2] Shanghai Chest Hosp, Shanghai, Peoples R China
[3] Geneplus Beijing, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
HER2; amplification; TMB; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P53.07
引用
收藏
页码：S1128 / S1128
页数：1
相关论文
共 50 条
  • [1] Concurrent Mutations in Chinese Lung Cancer Patients Carrying HER2 Genomic Aberrations
    Zhao, J.
    Li, Y.
    Dong, X.
    Ai, X.
    Chen, Y.
    Lin, G.
    Zhang, X.
    Wang, W.
    Xu, C.
    Chen, R.
    Xia, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S482 - S483
  • [2] HER2 amplification and microsatellite status distribution in Chinese gastric cancer patients
    Guo, Jun
    Jiang, Da
    Zhang, Wei
    Deng, Ting
    Niu, Zhaojian
    Chen, Wenting
    Shi, Junping
    Zhang, Shuirong
    Zhang, Lin
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Amplification of HER2 is a marker for global genomic instability
    Ellsworth, Rachel E.
    Ellsworth, Darrell L.
    Patney, Heather L.
    Deyarmin, Brenda
    Love, Brad
    Hooke, Jeffrey A.
    Shriver, Craig D.
    BMC CANCER, 2008, 8 (1)
  • [4] Amplification of HER2 is a marker for global genomic instability
    Rachel E Ellsworth
    Darrell L Ellsworth
    Heather L Patney
    Brenda Deyarmin
    Brad Love
    Jeffrey A Hooke
    Craig D Shriver
    BMC Cancer, 8
  • [5] HER2 and lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (10) : 1219 - 1228
  • [6] HER2 mutations in Chinese patients with non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Shi, Zhiyong
    Zhao, Jun
    Zhang, Yiping
    ONCOTARGET, 2016, 7 (47) : 78152 - 78158
  • [7] HER2 Mutations in Chinese Patients with Non-Small Cell Lung Cancer
    Song, Zhengbo
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S494 - S495
  • [8] HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
    Li, Bob T.
    Ross, Dara S.
    Aisner, Dara L.
    Chaft, Jamie E.
    Hsu, Meier
    Kako, Severine L.
    Kris, Mark G.
    Varella-Garcia, Marileila
    Arcila, Maria E.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (03) : 414 - 419
  • [9] Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
    Lauterlein, Jens-Jacob L.
    Petersen, Eva R. B.
    Olsen, Dorte Aa
    Ostergaard, Birthe
    Brandslund, Ivan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 877 - 883
  • [10] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Horimoto, Yoshiya
    Ishizuka, Yumiko
    Ueki, Yuko
    Higuchi, Toru
    Arakawa, Atsushi
    Saito, Mitsue
    BMC CANCER, 2022, 22 (01)
12345